Copyright
©The Author(s) 2022.
World J Clin Cases. Sep 16, 2022; 10(26): 9285-9302
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9285
Published online Sep 16, 2022. doi: 10.12998/wjcc.v10.i26.9285
Table 2 Clinical baseline data of lung adenocarcinoma patients
| Variable | TCGA cohort | GEO cohort |
| Patients (n) | 445 | 439 |
| Sex | ||
| Female | 245 (55.1%) | 218 (49.7%) |
| Male | 200 (44.9%) | 221 (50.3%) |
| Age, yr | ||
| < 65 | 199 (44.7%) | 213 (48.5%) |
| ≥ 65 | 246 (55.3%) | 226 (51.5%) |
| TNM stage | ||
| Ι | 241 (54.2%) | 274 (62.4%) |
| Ⅱ | 107 (24.0%) | 95 (21.6%) |
| Ⅲ | 74 (16.4%) | 67 (15.3%) |
| Ⅳ | 24 (5.4%) | 0 |
| Unknown | 0 | 3 (0.7%) |
| T stage | ||
| T1 | 154 (34.6%) | 149 (33.9%) |
| T2 | 234 (52.6%) | 248 (56.5%) |
| T3 | 37 (8.3%) | 28 (6.4%) |
| T4 | 17 (3.8%) | 11 (2.5%) |
| Tx | 3 (0.7%) | 3 (0.7%) |
| Survival status | ||
| OS time, median days | 653 | 1418 |
| Censored (%) | 170 (38.2%) | 233 (53.1%) |
- Citation: Zhou DH, Du QC, Fu Z, Wang XY, Zhou L, Wang J, Hu CK, Liu S, Li JM, Ma ML, Yu H. Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis. World J Clin Cases 2022; 10(26): 9285-9302
- URL: https://www.wjgnet.com/2307-8960/full/v10/i26/9285.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i26.9285